Patterns of breast magnetic resonance imaging use in community practice

JAMA Internal Medicine

Volumn 174, Issue 1, 2014, Pages 125-132

  Wernli, Karen J ^a   DeMartini, Wendy B ^b   Ichikawa, Laura ^a   Lehman, Constance D ^b   Onega, Tracy ^c   Kerlikowske, Karla ^d,e   Henderson, Louise M ^f   Geller, Berta M ^g,h   Hofmann, Mike ^e   Yankaskas, Bonnie C ^f  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST; BREAST CANCER; BREAST EXAMINATION; CANCER RECURRENCE; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER STAGING; COHORT ANALYSIS; COMMUNITY CARE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIFESPAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BREAST; BREAST NEOPLASMS; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84892397335     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.11963     Document Type: Article

References (29)

1. US Food and Drug Administration. MQSA National Statistics. http://www.fda.gov/Radiation-EmittingProducts/ MammographyQualityStandardsActandProgram/FacilityScorecard/ucm113858.htm. 2012. Accessed October 9, 2012.
2. Howlader N, Noone AM, Krapcho M, et a.l., eds. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute; 2011. http://seer.cancer.gov/csr/1975-2008/. Accessed May 12, 2012.
3. Stout NK, Nekhlyudov L. Early uptake of breast magnetic resonance imaging in a community-based medical practice, 2000-2004. J Womens Health (Larchmt). 2011;20(4):631-634.
4. Elmore L, Margenthaler JA Breast MRI surveillance in women with prior curative-intent therapy for breast cancer. J Surg Res. 2010;163(1):58-62.
5. Smith RA, Cokkinides V, Brooks D., Saslow D, Brawley OW Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2010;60(2):99-119.
6. Lehman CD, DeMartini W, Anderson B.O., Edge SB Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw. 2009;7(2):193-201.
7. Elmore L, Margenthaler JA Use of breast MRI surveillance in women at high risk for breast cancer: a single-institutional experience. Ann Surg Oncol. 2010;17(SUPPL. 3):263-267.
8. Sommer CA, Stitzenberg KB, Tolleson-Rinehart S, Carpenter W.R., Carey TS Breast MRI utilization in older patients with newly diagnosed breast cancer. J Surg Res. 2011;170(1):77-83.
9. Kriege M, Brekelmans CT, Obdeijn I.M., et al Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer. Breast Cancer Res Treat. 2006;100(1):109-119.
10. Leach MO, Boggis CR, Dixon A.K., et al.; MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet. 2005;365(9473):1769-1778.
11. Saslow D, Boetes C, Burke W., et al.; American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57(2):75-89.
12. Lehman CD, Smith RA The role of MRI in breast cancer screening. J Natl Compr Canc Netw. 2009;7(10):1109-1115.
13. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Breast Cancer. Version 3. 2013. http://www.nccn.org/professionals/physician-gls/pdf/breast.pdf. Accessed October 17, 2013.
14. Ballard-Barbash R., Taplin SH, Yankaskas B.C., et al.; Breast Cancer Surveillance Consortium. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. AJR Am J Roentgenol. 1997;169(4):1001-1008.
15. American College of Radiology Breast Imaging Reporting and Data System Atlas. Reston, VA: American College of Radiology; 2003.
16. Costantino JP, Gail MH, Pee D, et al Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst. 1999;91(18):1541-1548.
17. Gail MH, Brinton LA, Byar D.P., et al Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-1886.
18. Gail MH, Costantino JP, Pee D, et al Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst. 2007;99(23):1782-1792.
19. Matsuno RK, Costantino JP, Ziegler R.G., et al Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst. 2011;103(12):951-961.
20. Rockhill B, Spiegelman D, Byrne C., Hunter DJ, Colditz GA Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001;93(5):358-366.
21. Bluemke DA, Gatsonis CA, Chen M.H., et al Magnetic resonance imaging of the breast prior to biopsy. JAMA. 2004;292(22):2735-2742.
22. Miller JW, Sabatino SA, Thompson T.D., et al Breast MRI use uncommon among US women. Cancer Epidemiol Biomarkers Prev. 2012;22(1):159-166.
23. Buxton JA, Bottorff JL, Balneaves L.G., et al Women's perceptions of breast cancer risk: are they accurate? Can J Public Health. 2003;94(6): 422-426.
24. Haas JS, Kaplan CP, Des Jarlais G, Gildengoin V, Pérez-Stable EJ, Kerlikowske K. Perceived risk of breast cancer among women at average and increased risk. J Womens Health (Larchmt). 2005;14(9):845-851.
25. Haas JS, Kaplan CP, Gregorich S.E., Pérez-Stable EJ, Des Jarlais G. Do physicians tailor their recommendations for breast cancer risk reduction based on patient's risk? J Gen Intern Med. 2004;19(4):302-309.
26. Berg WA, Gutierrez L, NessAiver M.S., et al Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233(3):830-849.
27. Brinton JT, Barke LD, Freivogel M.E., Jackson S., O'Donnell CI, Glueck DH Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic. Acad Radiol. 2012;19(1):95-99.
28. Berg WA, Blume JD, Adams A.M., et al Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology. 2010;254(1):79-87.
29. Ozanne EM, Drohan B, Bosinoff P., et al Which risk model to use? clinical implications of the ACS MRI screening guidelines. Cancer Epidemiol Biomarkers Prev. 2013;22(1):146-149.